Zobrazeno 1 - 10
of 39
pro vyhledávání: '"J. Feighner"'
Autor:
J. Feighner, Matzura-Wolfe D, Solbach Mp, Polis A, Mark S. Kramer, Scott A. Reines, Silberstein S, Amaraneni Pg, McHugh W, Getson A
Publikováno v:
Neurology. 51:773-781
Objective: To examine the safety and efficacy of rizatriptan 10 mg PO in the treatment of multiple migraine attacks.Background: Rizatriptan is a potent and rapidly absorbed 5-HT1B/1D receptor agonist. Efficacy and general safety have been examined in
Autor:
J, Feighner
Publikováno v:
Postgraduate medicine. 106
The evolution of the diagnosis of GAD over the past 20 years generated a need for rigorous double-blind, placebo-controlled studies of drug therapies for GAD that are based on current DSM-IV diagnostic criteria. Serving as the current model for evalu
Autor:
M S, Kramer, D, Matzura-Wolfe, A, Polis, A, Getson, P G, Amaraneni, M P, Solbach, W, McHugh, J, Feighner, S, Silberstein, S A, Reines
Publikováno v:
Neurology. 51(3)
To examine the safety and efficacy of rizatriptan 10 mg PO in the treatment of multiple migraine attacks.Rizatriptan is a potent and rapidly absorbed 5-HT1B/1D receptor agonist. Efficacy and general safety have been examined in controlled trials trea
Autor:
R K, Shrivastava, C, Cohn, J, Crowder, J, Davidson, D, Dunner, J, Feighner, A, Kiev, R, Patrick
Publikováno v:
Journal of clinical psychopharmacology. 14(5)
The antidepressant efficacy and safety of venlafaxine was shown previously in 6-week, placebo-controlled trials. We evaluated the long-term safety and clinical acceptability of venlafaxine and imipramine in a double-blind, parallel-group, comparative
Publikováno v:
The Journal of clinical psychiatry. 55(3)
Venlafaxine is a new phenylethylamine antidepressant that exhibits monoamine reuptake inhibition. The current study evaluates the efficacy of venlafaxine compared to that of imipramine in outpatients suffering from major depression of moderate-to-mar
Autor:
J.S. Carman, Mark S. Kramer, N.R. Cutler, Duane B. Snavely, Nadia M.J. Rupniak, Guanghan Liu, Ram K. Shrivastava, J. Feighner, Edwina Wyatt-Knowles, Scott A. Reines
Publikováno v:
Biological Psychiatry. 47:S11
Publikováno v:
European Neuropsychopharmacology. 6:48
P-2-87 Comparison of the safety and tolerance of fluvoxamine and sertraline in depressed outpatients
Autor:
P.T. Ninan, James C. Ballenger, W.M. Patterson, Charles B. Nemeroff, J. Feighner, John H. Greist
Publikováno v:
European Neuropsychopharmacology. 5:304
Publikováno v:
Clinical Neuropharmacology. 15:208B
Publikováno v:
Diseases of the nervous system. 37(9)